Treat psoriasis at home: Ultraviolet lamps
Psoriasis patients find home treatment less burdensome, equally safe and effective as UVB treatment in clinical settings
7 May, 2009 -- Home treatment of the skin ailment psoriasis with ultraviolet
light lamps is at least as safe and effective as conventional phototherapy at
hospitals or clinics, according to new multinational research.
Ultraviolet B treatment involves exposing the skin to an artificial UVB
light source. People find home therapy less of a burden and are more satisfied
with it than in clinical settings, researchers from the Netherlands and Germany
Psoriasis is a common, chronic inflammatory skin condition that can cause
Although light therapy is safe and effective, the researchers say few people
in Great Britain ever receive it because of limited availability of UVB light
boxes, and time constraints of UV treatment at hospitals or clinics. Typically,
a course of treatment requires three visits per week for eight to 10 weeks.
Another reason light therapy isn’t widely done at home is that most
dermatologists believe home therapy is inferior to treatments administered in a
medical setting, and carries more risks, although researchers say that there is
no evidence to support such beliefs.
The research team from the Netherlands’ University Medical Center Utrecht at
the University of Groningen, and Germany’s St. Antonius Hospital, compared the
safety and effectiveness of home phototherapy with standard hospital-based
They identified 196 people with psoriasis at 14 hospital dermatology
departments in the Netherlands. Then they randomized patients to receive either
UVB light therapy at home or as an outpatient at a hospital.
Both the people treated at home and in a hospital setting received light
therapy according to standard practice.
During the study, disease severity after treatment was measured using
commonly used scoring scales.
Both groups completed questionnaires that asked about quality of life, the
burdensome nature of the treatment, and satisfaction levels.
Effectiveness of treatment was significant and similar in both groups. The
authors also report that cumulative doses of UVB and short-term side effects
were also similar in both groups.
The patients treated at home reported a significantly lower treatment burden
and greater satisfaction with their therapy. And most of the people said they
would prefer getting the treatment at home rather than in hospitals in the
future, the researchers say.
The researchers conclude that UVB phototherapy at home should be considered
as a good alternative and suggest that current guidelines for home use of
lighting equipment ought to be updated.
“Ultraviolet B phototherapy at home poses a lower burden, is better
appreciated, and gives similar improvements in quality of life”, the
researchers write, adding that empowering patients might increase their use of
recommended topical medicines.
Also, they say, home therapy could be started sooner after episode
flare-ups, reducing stress factors that influence the severity of the
Professor Alex Anstey of the Royal Gwent Hospital in Newport, Wales, says in
an editorial that it’s clear conventional treatment methods need to be
reassessed. Also, he says health care officials should work with dermatologists
to improve access to the UVB devices that for some time have been widely
available in the US with a doctor’s prescription.
The study is published in bmj.com.